Trial Profile
Beijing Pre-diabetes Reversion Program.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from Jul 2007 to Jun 2010 as reported by ClinicalTrials.gov.
- 24 Jun 2009 New trial record